💨 Abstract

CytoSorbents Corp. (CTSO), based in Princeton, New Jersey, reported a $1.5 million loss in its first quarter of 2025, equating to a 2 cents per share loss. After adjusting for non-recurring gains, the loss was 6 cents per share. The blood purification therapy company reported $8.7 million in revenue for the period.

Courtesy: wtop.com